Neuroinflammatory mechanisms contribute to the brain pathology resulting from human immunodeficiency virus (HIV) infection. Magnetic resonance spectroscopy (MRS) has been touted as a suitable method for discriminatingin vivomarkers of neuroinflammation. The presentMRSstudy was conducted in four groups: alcohol dependent (A, n = 37),HIV‐infected (H, n = 33), alcohol dependent + HIVinfected (HA, n = 38) and healthy control (C, n = 62) individuals to determine whether metabolites would change in a pattern reflecting neuroinflammation. Significant four‐group comparisons were evident only for striatal choline‐containing compounds (Cho) and myo‐inositol (mI), which follow‐up analysis demonstrated were due to higher levels inHAcompared withCindividuals. To explore the potential relevance of elevatedCho andmI, correlations between blood markers, medication status and alcohol consumption were evaluated inH + HAsubjects. Having an acquired immune deficiency syndrome (AIDS)‐defining event or hepatitisCwas associated with higherCho; lowerCho levels, however, were associated with low thiamine levels and with highly active antiretroviralHIVtreatment (HAART). Higher levels ofmIwere related to greater lifetime alcohol consumed, whereasHAARTwas associated with lowermIlevels. The current results suggest that competing mechanisms can influencein vivo Cho andmIlevels, and that elevations in these metabolites cannot necessarily be interpreted as reflecting a single underlying mechanism, including neuroinflammation.